<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"><channel><title>3TC</title><link>http://www.unboundmedicine.com/medline/ebm/research/3TC</link><description>Unbound MEDLINE is a service provided by Unbound Medicine, Inc. that includes data and services from the U.S. National Library of Medicine's MEDLINE® and PubMed® databases.</description><language>en-us</language><copyright>Unbound Medicine, Inc.</copyright><item><title>The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18845950/full_citation/The_Relationship_Between_Resistance_and_Adherence_in_Drug_Naive_Individuals_Initiating_HAART_Is_Specific_to_Individual_Drug_Classes_</link><description>Tam LW, Chui CK, Brumme CJ, et al. <br/><span class="title">The Relationship Between Resistance and Adherence in Drug-Naive Individuals Initiating HAART Is Specific to Individual Drug Classes. [JOURNAL ARTICLE]</span><br/><span class="source" title="Journal of acquired immune deficiency syndromes (1999)">J Acquir Immune Defic Syndr 2008 Oct 3.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18845950/abstract/The_Relationship_Between_Resistance_and_Adherence_in_Drug_Naive_Individuals_Initiating_HAART_Is_Specific_to_Individual_Drug_Classes_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18845950/full_citation/The_Relationship_Between_Resistance_and_Adherence_in_Drug_Naive_Individuals_Initiating_HAART_Is_Specific_to_Individual_Drug_Classes_">Full Citation</a></description></item><item><title>Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada(R)) in virologically suppressed HIV-infected patients on HAART.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18841401/full_citation/Effectiveness_and_safety_of_simplification_from_tenofovir_lamivudine__TDF_3TC__to_tenofovir_emtricitabine__TDF_FTC__co_formulation__Truvada_R___in_virologically_suppressed_HIV_infected_patients_on_HAART_</link><description>Palacios R, Hidalgo C, Ríos MJ, et al. <br/><span class="title">Effectiveness and safety of simplification from tenofovir-lamivudine (TDF-3TC) to tenofovir-emtricitabine (TDF-FTC) co-formulation (Truvada(R)) in virologically suppressed HIV-infected patients on HAART. [JOURNAL ARTICLE]</span><br/><span class="source" title="European journal of clinical microbiology &amp; infectious diseases : official publication of the European Society of Clinical Microbiology">Eur J Clin Microbiol Infect Dis 2008 Oct 8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18841401/abstract/Effectiveness_and_safety_of_simplification_from_tenofovir_lamivudine__TDF_3TC__to_tenofovir_emtricitabine__TDF_FTC__co_formulation__Truvada_R___in_virologically_suppressed_HIV_infected_patients_on_HAART_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18841401/full_citation/Effectiveness_and_safety_of_simplification_from_tenofovir_lamivudine__TDF_3TC__to_tenofovir_emtricitabine__TDF_FTC__co_formulation__Truvada_R___in_virologically_suppressed_HIV_infected_patients_on_HAART_">Full Citation</a></description></item><item><title>Reverse Transcriptase Activity of Hepatitis B virus Polymerase in Eukaryotic Cell Extracts In Vitro.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18841316/full_citation/Reverse_Transcriptase_Activity_of_Hepatitis_B_virus_Polymerase_in_Eukaryotic_Cell_Extracts_In_Vitro_</link><description>Favre D <br/><span class="title">Reverse Transcriptase Activity of Hepatitis B virus Polymerase in Eukaryotic Cell Extracts In Vitro. [Journal Article]</span><br/><span class="source" title="ALTEX : Alternativen zu Tierexperimenten">ALTEX 2008; 25(3):197-211.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18841316/abstract/Reverse_Transcriptase_Activity_of_Hepatitis_B_virus_Polymerase_in_Eukaryotic_Cell_Extracts_In_Vitro_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18841316/full_citation/Reverse_Transcriptase_Activity_of_Hepatitis_B_virus_Polymerase_in_Eukaryotic_Cell_Extracts_In_Vitro_">Full Citation</a></description></item><item><title>The Impacts of Current Antiretroviral Therapy Regimens on Chinese AIDS Patients and Their Implications for HIV-1 Drug Resistance Mutation.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18806342/full_citation/The_Impacts_of_Current_Antiretroviral_Therapy_Regimens_on_Chinese_AIDS_Patients_and_Their_Implications_for_HIV_1_Drug_Resistance_Mutation_</link><description>Zhang M, Han XX, Cui WG, et al. <br/><span class="title">The Impacts of Current Antiretroviral Therapy Regimens on Chinese AIDS Patients and Their Implications for HIV-1 Drug Resistance Mutation. [Journal Article]</span><br/><span class="source" title="Japanese journal of infectious diseases">Jpn J Infect Dis 2008 Sep; 61(5):361-5.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18806342/abstract/The_Impacts_of_Current_Antiretroviral_Therapy_Regimens_on_Chinese_AIDS_Patients_and_Their_Implications_for_HIV_1_Drug_Resistance_Mutation_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18806342/full_citation/The_Impacts_of_Current_Antiretroviral_Therapy_Regimens_on_Chinese_AIDS_Patients_and_Their_Implications_for_HIV_1_Drug_Resistance_Mutation_">Full Citation</a></description></item><item><title>Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18795964/full_citation/Liver_enzyme_elevation_after_lamivudine_withdrawal_in_HIV_hepatitis_B_virus_co_infected_patients:_the_Swiss_HIV_Cohort_Study_</link><description>Bellini C, Keiser O, Chave JP, et al. <br/><span class="title">Liver enzyme elevation after lamivudine withdrawal in HIV-hepatitis B virus co-infected patients: the Swiss HIV Cohort Study. [JOURNAL ARTICLE]</span><br/><span class="source" title="HIV medicine">HIV Med 2008 Sep 12.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18795964/abstract/Liver_enzyme_elevation_after_lamivudine_withdrawal_in_HIV_hepatitis_B_virus_co_infected_patients:_the_Swiss_HIV_Cohort_Study_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18795964/full_citation/Liver_enzyme_elevation_after_lamivudine_withdrawal_in_HIV_hepatitis_B_virus_co_infected_patients:_the_Swiss_HIV_Cohort_Study_">Full Citation</a></description></item><item><title>Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18781872/full_citation/Didanosine_Lamivudine_and_Efavirenz_versus_Zidovudine_Lamivudine_and_Efavirenz_for_the_Initial_Treatment_of_HIV_Type_1_Infection:_Final_Analysis__48_Weeks__of_a_Prospective_Randomized_Noninferiority_Clinical_Trial_GESIDA_3903_</link><description>Berenguer J, González J, Ribera E, et al. <br/><span class="title">Didanosine, Lamivudine, and Efavirenz versus Zidovudine, Lamivudine, and Efavirenz for the Initial Treatment of HIV Type 1 Infection: Final Analysis (48 Weeks) of a Prospective, Randomized, Noninferiority Clinical Trial, GESIDA 3903. [JOURNAL ARTICLE]</span><br/><span class="source" title="Clinical infectious diseases : an official publication of the Infectious Diseases Society of America">Clin Infect Dis 2008 Sep 9.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18781872/abstract/Didanosine_Lamivudine_and_Efavirenz_versus_Zidovudine_Lamivudine_and_Efavirenz_for_the_Initial_Treatment_of_HIV_Type_1_Infection:_Final_Analysis__48_Weeks__of_a_Prospective_Randomized_Noninferiority_Clinical_Trial_GESIDA_3903_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18781872/full_citation/Didanosine_Lamivudine_and_Efavirenz_versus_Zidovudine_Lamivudine_and_Efavirenz_for_the_Initial_Treatment_of_HIV_Type_1_Infection:_Final_Analysis__48_Weeks__of_a_Prospective_Randomized_Noninferiority_Clinical_Trial_GESIDA_3903_">Full Citation</a></description></item><item><title>New depot forms of AZT and 3TC based on their phosphonate derivatives: anti-HIV activity and pharmacokinetic parameters.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18776521/full_citation/New_depot_forms_of_AZT_and_3TC_based_on_their_phosphonate_derivatives:_anti_HIV_activity_and_pharmacokinetic_parameters_</link><description>Kukhanova MK, Jasco MV, Shipitzyn AV, et al. <br/><span class="title">New depot forms of AZT and 3TC based on their phosphonate derivatives: anti-HIV activity and pharmacokinetic parameters. [Journal Article]</span><br/><span class="source" title="Nucleic acids symposium series (2004)">Nucleic Acids Symp Ser (Oxf) 2008; (52):597-8.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18776521/abstract/New_depot_forms_of_AZT_and_3TC_based_on_their_phosphonate_derivatives:_anti_HIV_activity_and_pharmacokinetic_parameters_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18776521/full_citation/New_depot_forms_of_AZT_and_3TC_based_on_their_phosphonate_derivatives:_anti_HIV_activity_and_pharmacokinetic_parameters_">Full Citation</a></description></item><item><title>Understanding the molecular basis of HBV drug resistance by molecular modeling.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18765256/full_citation/Understanding_the_molecular_basis_of_HBV_drug_resistance_by_molecular_modeling_</link><description>Sharon A, Chu CK <br/><span class="title">Understanding the molecular basis of HBV drug resistance by molecular modeling. [JOURNAL ARTICLE]</span><br/><span class="source" title="Antiviral research">Antiviral Res 2008 Aug 30.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18765256/abstract/Understanding_the_molecular_basis_of_HBV_drug_resistance_by_molecular_modeling_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18765256/full_citation/Understanding_the_molecular_basis_of_HBV_drug_resistance_by_molecular_modeling_">Full Citation</a></description></item><item><title>Studies on Antiretroviral Drug Concentrations in Breast Milk: Validation of a Liquid Chromatography-Tandem Mass Spectrometric Method for the Determination of 7 Anti-Human Immunodeficiency Virus Medications.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18758393/full_citation/Studies_on_Antiretroviral_Drug_Concentrations_in_Breast_Milk:_Validation_of_a_Liquid_Chromatography_Tandem_Mass_Spectrometric_Method_for_the_Determination_of_7_Anti_Human_Immunodeficiency_Virus_Medications_</link><description>Rezk NL, White N, Bridges AS, et al. <br/><span class="title">Studies on Antiretroviral Drug Concentrations in Breast Milk: Validation of a Liquid Chromatography-Tandem Mass Spectrometric Method for the Determination of 7 Anti-Human Immunodeficiency Virus Medications. [JOURNAL ARTICLE]</span><br/><span class="source" title="Therapeutic drug monitoring">Ther Drug Monit 2008 Aug 27.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18758393/abstract/Studies_on_Antiretroviral_Drug_Concentrations_in_Breast_Milk:_Validation_of_a_Liquid_Chromatography_Tandem_Mass_Spectrometric_Method_for_the_Determination_of_7_Anti_Human_Immunodeficiency_Virus_Medications_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18758393/full_citation/Studies_on_Antiretroviral_Drug_Concentrations_in_Breast_Milk:_Validation_of_a_Liquid_Chromatography_Tandem_Mass_Spectrometric_Method_for_the_Determination_of_7_Anti_Human_Immunodeficiency_Virus_Medications_">Full Citation</a></description></item><item><title>Antiviral Effect of Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Tenofovir Disoproxil Fumarate, Adminstered Orally Alone and in Combination, to Woodchucks with Chronic Woodchuck Hepatitis Virus Infection.</title><link>http://www.unboundmedicine.com/medline/ebm/record/18676881/full_citation/Antiviral_Effect_of_Lamivudine_Emtricitabine_Adefovir_Dipivoxil_and_Tenofovir_Disoproxil_Fumarate_Adminstered_Orally_Alone_and_in_Combination_to_Woodchucks_with_Chronic_Woodchuck_Hepatitis_Virus_Infection_</link><description>Menne S, Butler SD, George AL, et al. <br/><span class="title">Antiviral Effect of Lamivudine, Emtricitabine, Adefovir Dipivoxil, and Tenofovir Disoproxil Fumarate, Adminstered Orally Alone and in Combination, to Woodchucks with Chronic Woodchuck Hepatitis Virus Infection. [JOURNAL ARTICLE]</span><br/><span class="source" title="Antimicrobial agents and chemotherapy">Antimicrob Agents Chemother 2008 Aug 1.</span><br/> <a href="http://www.unboundmedicine.com/medline/ebm/record/18676881/abstract/Antiviral_Effect_of_Lamivudine_Emtricitabine_Adefovir_Dipivoxil_and_Tenofovir_Disoproxil_Fumarate_Adminstered_Orally_Alone_and_in_Combination_to_Woodchucks_with_Chronic_Woodchuck_Hepatitis_Virus_Infection_">Abstract</a> | <a href="http://www.unboundmedicine.com/medline/ebm/record/18676881/full_citation/Antiviral_Effect_of_Lamivudine_Emtricitabine_Adefovir_Dipivoxil_and_Tenofovir_Disoproxil_Fumarate_Adminstered_Orally_Alone_and_in_Combination_to_Woodchucks_with_Chronic_Woodchuck_Hepatitis_Virus_Infection_">Full Citation</a></description></item></channel></rss>